Mitsubishi UFJ Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.73B Buy
1,882,027
+130,751
+7% +$133M 1.16% 14
2025
Q4
$1.89B Buy
1,751,276
+97,106
+6% +$92.9M 1.28% 12
2025
Q3
$1.26B Buy
1,654,170
+77,931
+5% +$58M 0.91% 15
2025
Q2
$1.23B Buy
1,576,239
+103,708
+7% +$80.6M 0.98% 15
2025
Q1
$1.22B Buy
1,472,531
+168,539
+13% +$140M 1.12% 14
2024
Q4
$1.02B Buy
1,303,992
+137,287
+12% +$114M 0.99% 16
2024
Q3
$1.03B Buy
1,166,705
+86,472
+8% +$77.7M 1.1% 14
2024
Q2
$978M Buy
1,080,233
+123,608
+13% +$98.9M 1.19% 12
2024
Q1
$744M Buy
956,625
+163,578
+21% +$116M 1.03% 17
2023
Q4
$490M Buy
793,047
+49,539
+7% +$28.9M 0.86% 25
2023
Q3
$399M Buy
743,508
+46,021
+7% +$23.7M 0.81% 27
2023
Q2
$327M Buy
697,487
+48,752
+8% +$20.4M 0.68% 31
2023
Q1
$223M Buy
648,735
+60,509
+10% +$20.4M 0.53% 44
2022
Q4
$215M Buy
588,226
+65,740
+13% +$23.3M 0.59% 39
2022
Q3
$169M Buy
522,486
+45,902
+10% +$14.5M 0.54% 39
2022
Q2
$155M Buy
476,584
+34,610
+8% +$10.4M 0.68% 24
2022
Q1
$127M Buy
441,974
+39,726
+10% +$10.2M 0.5% 34
2021
Q4
$109M Buy
402,248
+57,854
+17% +$14.7M 0.43% 43
2021
Q3
$79.6M Buy
344,394
+28,334
+9% +$6.99M 0.39% 53
2021
Q2
$72.5M Buy
316,060
+28,019
+10% +$5.63M 0.4% 50
2021
Q1
$53.8M Buy
288,041
+29,917
+12% +$5.85M 0.35% 60
2020
Q4
$43.6M Buy
258,124
+9,552
+4% +$1.43M 0.34% 62
2020
Q3
$36.8M Buy
248,572
+28,962
+13% +$4.48M 0.34% 70
2020
Q2
$36.1M Buy
219,610
+18,472
+9% +$2.84M 0.41% 50
2020
Q1
$27.9M Sell
201,138
-9,761
-5% -$1.34M 0.43% 49
2019
Q4
$27.8M Buy
210,899
+19,822
+10% +$2.3M 0.36% 60
2019
Q3
$21.4M Buy
191,077
+161
+0.1% +$17.9K 0.35% 59
2019
Q2
$21.2M Buy
190,916
+25,901
+16% +$3.05M 0.36% 59
2019
Q1
$21.4M Sell
165,015
-3,856
-2% -$469K 0.44% 50
2018
Q4
$18.8M Sell
168,871
-19,704
-10% -$2.2M 0.47% 41
2018
Q3
$20.2M Sell
188,575
-9,181
-5% -$918K 0.42% 55
2018
Q2
$16.9M Buy
197,756
+2,954
+2% +$243K 0.37% 59
2018
Q1
$15.1M Sell
194,802
-40,455
-17% -$3.26M 0.35% 58
2017
Q4
$20M Sell
235,257
-1,783
-0.8% -$152K 0.43% 48
2017
Q3
$20.3M Buy
237,040
+3,872
+2% +$318K 0.48% 47
2017
Q2
$19.2M Sell
233,168
-13,814
-6% -$1.13M 0.47% 48
2017
Q1
$20.8M Buy
246,982
+18,714
+8% +$1.5M 0.47% 44
2016
Q4
$17M Buy
228,268
+22,886
+11% +$1.7M 0.41% 56
2016
Q3
$16.5M Buy
205,382
+5,543
+3% +$444K 0.41% 62
2016
Q2
$15.7M Buy
199,839
+30,982
+18% +$2.33M 0.41% 62
2016
Q1
$12.2M Buy
168,857
+29,770
+21% +$2.25M 0.33% 68
2015
Q4
$11.7M Buy
139,087
+6,930
+5% +$575K 0.34% 67
2015
Q3
$11.1M Sell
132,157
-1,142
-0.9% -$96.4K 0.35% 65
2015
Q2
$11.1M Sell
133,299
-9,534
-7% -$726K 0.34% 65
2015
Q1
$10.4M Sell
142,833
-8,668
-6% -$617K 0.31% 67
2014
Q4
$10.6M Sell
151,501
-21,397
-12% -$1.44M 0.33% 66
2014
Q3
$11.2M Sell
172,898
-22,723
-12% -$1.44M 0.34% 66
2014
Q2
$12.2M Sell
195,621
-2,270
-1% -$135K 0.31% 77
2014
Q1
$11.6M Buy
197,891
+10,684
+6% +$596K 0.31% 73
2013
Q4
$9.57M Sell
187,207
-65,257
-26% -$3.27M 0.27% 83
2013
Q3
$12.7M Buy
252,464
+30,564
+14% +$1.6M 0.33% 72
2013
Q2
$10.9M Buy
+221,900
New +$12.1M 0.31% 73

Other funds holding LLY

Mitsubishi UFJ Asset Management's LLY Position: Q1 2026 in Review

Mitsubishi UFJ Asset Management increased its Eli Lilly (LLY) stake by 7.5% in Q1 2026, buying an estimated $133M and bringing the position to 1,882,027 shares worth $1.73B. The position accounts for 1.16% of the portfolio, ranked #14.

Mitsubishi UFJ Asset Management first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.89B in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Mitsubishi UFJ Asset Management held 1,882,027 shares of Eli Lilly worth $1.73B as of Q1 2026.
  • Mitsubishi UFJ Asset Management bought 130,751 Eli Lilly shares in Q1 2026, an estimated $133M.
  • Eli Lilly made up 1.16% of Mitsubishi UFJ Asset Management's portfolio in Q1 2026, its #14 holding.
  • Mitsubishi UFJ Asset Management first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Mitsubishi UFJ Asset Management's Eli Lilly position peaked at $1.89B in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q1 2026, filed 12 May 2026.